A citation-based method for searching scientific literature

Anne-Marie Castonguay, Claude Gravel, Martin Lévesque. J Parkinsons Dis 2021
Times Cited: 10







List of co-cited articles
113 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial.
Dieter Volc, Werner Poewe, Alexandra Kutzelnigg, Petra Lührs, Caroline Thun-Hohenstein, Achim Schneeberger, Gergana Galabova, Nour Majbour, Nishant Vaikath, Omar El-Agnaf,[...]. Lancet Neurol 2020
47
40

Clinical progression in Parkinson disease and the neurobiology of axons.
Hsiao-Chun Cheng, Christina M Ulane, Robert E Burke. Ann Neurol 2010
507
30

Diagnosis and Treatment of Parkinson Disease: A Review.
Melissa J Armstrong, Michael S Okun. JAMA 2020
486
30

Ten Unsolved Questions About Neuroinflammation in Parkinson's Disease.
Etienne C Hirsch, David G Standaert. Mov Disord 2021
58
30

Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson's disease model.
Diptaman Chatterjee, Mansi Bhatt, David Butler, Erwin De Genst, Christopher M Dobson, Anne Messer, Jeffrey H Kordower. NPJ Parkinsons Dis 2018
42
30

A Phase 1 Randomized Trial of Specific Active α-Synuclein Immunotherapies PD01A and PD03A in Multiple System Atrophy.
Wassilios G Meissner, Anne Pavy-Le Traon, Alexandra Foubert-Samier, Gergana Galabova, Monique Galitzky, Alexandra Kutzelnigg, Brice Laurens, Petra Lührs, Rossella Medori, Patrice Péran,[...]. Mov Disord 2020
24
30

Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease.
Jeffrey H Kordower, Yaping Chu, Robert A Hauser, Thomas B Freeman, C Warren Olanow. Nat Med 2008
30

Randomized phase I clinical trial of anti-α-synuclein antibody BIIB054.
Miroslaw Brys, Laura Fanning, Serena Hung, Aaron Ellenbogen, Natalia Penner, Minhua Yang, Mackenzie Welch, Erica Koenig, Eric David, Tara Fox,[...]. Mov Disord 2019
76
30

Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
Joanna A Korecka, Elizabeth B Moloney, Ruben Eggers, Barbara Hobo, Sanny Scheffer, Nienke Ras-Verloop, R Jeroen Pasterkamp, Dick F Swaab, August B Smit, Ronald E van Kesteren,[...]. J Neurosci 2017
17
20

Diagnostic staging of Parkinson's disease: conceptual aspects.
H Przuntek, Th Müller, P Riederer. J Neural Transm (Vienna) 2004
105
20

Repulsive guidance molecule-a and demyelination: implications for multiple sclerosis.
Takekazu Kubo, Shigeru Tokita, Toshihide Yamashita. J Neuroimmune Pharmacol 2012
12
20


Levodopa increases oxidative stress and repulsive guidance molecule A levels: a pilot study in patients with Parkinson's disease.
Thomas Müller, Isabel Trommer, Siegfried Muhlack, Bernhard K Mueller. J Neural Transm (Vienna) 2016
24
20


Neuroinflammation - a common thread in neurological disorders.
Nils Erik Gilhus, Günther Deuschl. Nat Rev Neurol 2019
58
20

Brain Microglial Activation Increased in Glucocerebrosidase (GBA) Mutation Carriers without Parkinson's disease.
Stephen Mullin, Morten Gersel Stokholm, Derralyn Hughes, Atul Mehta, Peter Parbo, Rainer Hinz, Nicola Pavese, David J Brooks, Anthony H V Schapira. Mov Disord 2021
22
20

Repulsive guidance molecules lock growth differentiation factor 5 in an inhibitory complex.
Tomas Malinauskas, Tina V Peer, Benjamin Bishop, Thomas D Mueller, Christian Siebold. Proc Natl Acad Sci U S A 2020
8
25

Alzheimer's disease.
C A Lane, J Hardy, J M Schott. Eur J Neurol 2018
850
20

Parkinson's disease and pesticides: A meta-analysis of disease connection and genetic alterations.
Hussien Ahmed, Abdelrahman Ibrahim Abushouk, Mohamed Gabr, Ahmed Negida, Mohamed M Abdel-Daim. Biomed Pharmacother 2017
52
20

Stem Cell-Based Therapies for Parkinson Disease.
Zhaohui Liu, Hoi-Hung Cheung. Int J Mol Sci 2020
17
20


Human-induced pluripotent stem cells pave the road for a better understanding of motor neuron disease.
Beate Winner, Maria C Marchetto, Jürgen Winkler, Fred H Gage. Hum Mol Genet 2014
16
20

The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017.
Günther Deuschl, Ettore Beghi, Franz Fazekas, Timea Varga, Kalliopi A Christoforidi, Eveline Sipido, Claudio L Bassetti, Theo Vos, Valery L Feigin. Lancet Public Health 2020
105
20

Repulsive Guidance Molecule A Suppresses Adult Neurogenesis.
Toke Jost Isaksen, Yuki Fujita, Toshihide Yamashita. Stem Cell Reports 2020
7
28


The neogenin/DCC homolog UNC-40 promotes BMP signaling via the RGM protein DRAG-1 in C. elegans.
Chenxi Tian, Herong Shi, Shan Xiong, Fenghua Hu, Wen-Cheng Xiong, Jun Liu. Development 2013
26
20

Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease.
Anthony E Lang, Steven Gill, Nik K Patel, Andres Lozano, John G Nutt, Richard Penn, David J Brooks, Gary Hotton, Elena Moro, Peter Heywood,[...]. Ann Neurol 2006
691
20

Is Braak staging valid for all types of Parkinson's disease?
Kurt A Jellinger. J Neural Transm (Vienna) 2019
46
20

Neuronal precursor cells with dopaminergic commitment in the rostral migratory stream of the mouse.
Kerstin Schweyer, Corinna Rüschoff-Steiner, Oscar Arias-Carrión, Wolfgang H Oertel, Thomas W Rösler, Günter U Höglinger. Sci Rep 2019
8
25

Multiplicity of α-Synuclein Aggregated Species and Their Possible Roles in Disease.
Pablo Gracia, José D Camino, Laura Volpicelli-Daley, Nunilo Cremades. Int J Mol Sci 2020
18
20

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.
Alan L Whone, Ray L Watts, A Jon Stoessl, Margaret Davis, Sven Reske, Claude Nahmias, Anthony E Lang, Olivier Rascol, Maria J Ribeiro, Philippe Remy,[...]. Ann Neurol 2003
601
20

Inhibition of repulsive guidance molecule-a protects dopaminergic neurons in a mouse model of Parkinson's disease.
Wakana Oda, Yuki Fujita, Kousuke Baba, Hideki Mochizuki, Hitoshi Niwa, Toshihide Yamashita. Cell Death Dis 2021
8
25




Cell-based therapy in Alzheimer's disease: Can human fetal cholinergic neurons "untangle the skein"?
Giulia Guarnieri, Erica Sarchielli, Gabriella B Vannelli, Annamaria Morelli. Neural Regen Res 2018
9
22

Decreased levels of repulsive guidance molecule A in association with beneficial effects of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients.
Thomas Müller, Stefan Barghorn, Sven Lütge, Thomas Haas, Reinhold Mueller, Bjoern Gerlach, Gabi Öhm, Katrin Eilert, Isabel Trommer, Bernhard K Mueller. J Neural Transm (Vienna) 2015
11
20

Tau phosphorylation, molecular chaperones, and ubiquitin E3 ligase: clinical relevance in Alzheimer's disease.
Pravir Kumar, Niraj Kumar Jha, Saurabh Kumar Jha, Karunya Ramani, Rashmi K Ambasta. J Alzheimers Dis 2015
34
20

Lewy Bodies: A Spectator or Salient Killer?
Jeswinder Sian-Hulsmann, Camelia Monoranu, S Strobel, Peter Riederer. CNS Neurol Disord Drug Targets 2015
21
20

Mechanisms of neuroplasticity and brain degeneration: strategies for protection during the aging process.
Mariana Toricelli, Arthur Antonio Ruiz Pereira, Guilherme Souza Abrao, Helena Nascimento Malerba, Julia Maia, Hudson Sousa Buck, Tania Araujo Viel. Neural Regen Res 2021
14
20

Biochemical and pharmacological aspects of Parkinsonism.
A Carlsson. Acta Neurol Scand Suppl 1972
54
20

Parkinson's Disease: Biomarkers, Treatment, and Risk Factors.
Fatemeh N Emamzadeh, Andrei Surguchov. Front Neurosci 2018
159
20

Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease.
Carroll Rutherford Fields, Nora Bengoa-Vergniory, Richard Wade-Martins. Front Mol Neurosci 2019
87
20

[The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].
W BIRKMAYER, O HORNYKIEWICZ. Wien Klin Wochenschr 1961
361
20


Penetrance of Glucocerebrosidase (GBA) Mutations in Parkinson's Disease: A Kin Cohort Study.
Roberta Balestrino, Sara Tunesi, Silvana Tesei, Leonardo Lopiano, Anna L Zecchinelli, Stefano Goldwurm. Mov Disord 2020
26
20

Pesticide-induced gene mutations and Parkinson disease risk: a meta-analysis.
Xiaowei Liu, Tao Ma, Bo Qu, Yan Ji, Zhi Liu. Genet Test Mol Biomarkers 2013
14
20


There is no Parkinson disease.
William J Weiner. Arch Neurol 2008
47
20

Ninety-day Local Tolerability and Toxicity Study of ND0612, a Novel Formulation of Levodopa/Carbidopa, Administered by Subcutaneous Continuous Infusion in Minipigs.
Yuval Ramot, Abraham Nyska, Robert R Maronpot, Ronit Shaltiel-Karyo, Yonit Tsarfati, Rosa Anna Manno, Giuseppe Sacco, Oron Yacoby-Zeevi. Toxicol Pathol 2017
18
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.